help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2002-0108
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
16/9/2019    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peng, B.
Right arrow Articles by Visvader, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, B.
Right arrow Articles by Visvader, J. E.
Molecular Endocrinology 16 (9): 2019-2033
Copyright © 2002 by The Endocrine Society

CPAP Is a Novel Stat5-Interacting Cofactor that Augments Stat5-Mediated Transcriptional Activity

Benjamin Peng, Kate D. Sutherland, Eleanor Y. M. Sum, Monilola Olayioye, Sergio Wittlin, Tang K. Tang, Geoffrey J. Lindeman and Jane E. Visvader

The Walter and Eliza Hall Institute of Medical Research & Rotary Bone Marrow Research Laboratories (B.P., K.D.S., E.Y.M.S., M.O., S.W., G.J.L., J.E.V.), Post Office Royal Melbourne Hospital, Victoria 3050, Australia; and Institute of Biomedical Sciences (T.K.T.), Academia Sinica, Taipei 115, Taiwan

Address all correspondence and requests for reprints to: Dr. Jane Visvader, Victorian Breast Cancer Research Consortium Laboratory, The Walter and Eliza Hall Institute of Medical Research, Post Office Royal Melbourne Hospital, Victoria 3050, Australia. E-mail: visvader{at}wehi.edu.au.

Stat5, a member of the signal transducer and activators of transcription (Stat) protein family, is a primary mediator of prolactin (PRL) signaling in the mammary gland. There are two distinct Stat5 genes, Stat5a and Stat5b. The Stat5a isoform has been demonstrated to have an essential role in mammary epithelial differentiation, whereas Stat5b is required for dimorphic sexual growth. To search for proteins that interact with the C terminus of Stat5a, a highly divergent region amongst Stat family members, we performed a yeast two-hybrid screen of HBL100 and primary breast adenocarcinoma libraries. This led to the identification of a protein that had previously been isolated as a centrosomal P4.1-associated protein (CPAP). CPAP was shown to specifically interact with Stat5a and Stat5b but not with Stat1 or Stat3. Both the tyrosine phosphorylated and unphosphorylated forms of Stat5, as well as Stat5a/Stat5b heterodimers, could associate with CPAP. CPAP was expressed in human breast cancer cell lines and the developing mammary gland as well as in other tissues. Indirect immunofluorescence and cellular fractionation studies revealed that CPAP was predominantly cytoplasmic, with low levels in the nucleus. Nuclear levels of CPAP increased substantially upon activation of the PRL pathway, most likely reflecting cotranslocation of this protein with activated Stat5. Furthermore, CPAP was found to augment Stat5-mediated transcription. Thus, we have identified CPAP as a novel coactivator of Stat5 proteins in the PRL (and probably other) pathways.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
S.-H. Tan and M. T Nevalainen
Signal transducer and activator of transcription 5A/B in prostate and breast cancers
Endocr. Relat. Cancer, June 1, 2008; 15(2): 367 - 390.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Ono, D. J. Chia, R. Merino-Martinez, A. Flores-Morales, T. G. Unterman, and P. Rotwein
Signal Transducer and Activator of Transcription (Stat) 5b-Mediated Inhibition of Insulin-Like Growth Factor Binding Protein-1 Gene Transcription: A Mechanism for Repression of Gene Expression by Growth Hormone
Mol. Endocrinol., June 1, 2007; 21(6): 1443 - 1457.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. M. Weaver and C. M. Silva
Modulation of Signal Transducer and Activator of Transcription 5b Activity in Breast Cancer Cells by Mutation of Tyrosines within the Transactivation Domain
Mol. Endocrinol., October 1, 2006; 20(10): 2392 - 2405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Koyanagi, M. Hijikata, K. Watashi, O. Masui, and K. Shimotohno
Centrosomal P4.1-associated Protein Is a New Member of Transcriptional Coactivators for Nuclear Factor-{kappa}B
J. Biol. Chem., April 1, 2005; 280(13): 12430 - 12437.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Davoodi-Semiromi, M. Laloraya, G. P. Kumar, S. Purohit, R. K. Jha, and J.-X. She
A Mutant Stat5b with Weaker DNA Binding Affinity Defines a Key Defective Pathway in Nonobese Diabetic Mice
J. Biol. Chem., March 19, 2004; 279(12): 11553 - 11561.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Woelfle, D. J. Chia, and P. Rotwein
Mechanisms of Growth Hormone (GH) Action: IDENTIFICATION OF CONSERVED Stat5 BINDING SITES THAT MEDIATE GH-INDUCED INSULIN-LIKE GROWTH FACTOR-I GENE ACTIVATION
J. Biol. Chem., December 19, 2003; 278(51): 51261 - 51266.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Paukku, J. Yang, and O. Silvennoinen
Tudor and Nuclease-Like Domains Containing Protein p100 Function as Coactivators for Signal Transducer and Activator of Transcription 5
Mol. Endocrinol., September 1, 2003; 17(9): 1805 - 1814.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society